The SARS-CoV-2 (COVID-19) IgA ELISA is intended for the qualitative determination of IgA class antibodies against SARS-CoV-2 in human serum or plasma (citrate, heparin) to support the diagnosis of COVID-19.
Información Requerida
Solicite una Quota
Caracteristicas
• Separate detection of IgA antibodys.
• SARS-CoV-2 Nucleocapsid recombinant antigen.
• Ideal complement to RT-PCR.
• Ready-to-use controls. Results in under two hours.
• Assay procedure is easy to automate.
• Works on any open ELISA system (protocols available).
• CE-IVD